HOXA-AS2 and acute kidney injury: According to a recent meta-analysis, MALAT1, CASC2, TapSAKI, XIST, and HOXA cluster antisense RNA 2 (HOXA-AS2) were considered to be the potential predictive biomarkers and therapeutic targets of AKI (123).